Review pending. Every figure has been located on its cited source page in an AI-assisted source verification (matched to the document's text) (9 October 2026). Independent review has not yet been carried out, and these pages are not indexed.AI-assisted source check done; independent review pending; not indexed. About the review
Astral Foods
On this page
Company details
- Legal name
- Astral Foods Limited
- Incorporated in
- South Africa
- Listing
- ARL on the A2X Markets, active · ISIN ZAE000029757 (observed 2026-10-08)
- Sector
- Not classified (our classification from the stated principal activity)
- Financial year ends
- 30 September
Overview
Year ended 30 September 2025 · annual report, final status not established · source
Read with these figures
- Annual report not confirmed as final. The published copy is unsigned. The FY to 30 Sep 2025 figures come from it.
Full wording and sources
Annual report for 2025: final status not established
The Integrated Report reproduces the independent auditor's report on the consolidated and separate financial statements (Deloitte & Touche, Registered Auditor, per Sebastian Carter, Partner), unqualified, dated 14 November 2025, with the firm and partner names typeset and no signature image (PDF pp147-149, page image). The Board's approval on 12 November 2025 is printed with the typeset names GD Arnold (CEO) and JAI Ferreira (CFO), no signature image (PDF p140). A signed copy would settle the final status.
Source: Astral Integrated Report for the year ended 30 September 2025 (dated 2025-11-14)
-
Revenue
ZAR 22.6 billion
22,619,153 ZAR thousands · p150
+10.4% vs 2024
-
Operating profit / (loss)
ZAR 1.25 billion
1,247,369 ZAR thousands · p150
+10.9% vs 2024
-
Profit / (loss) for the year
ZAR 876 million
876,389 ZAR thousands · p150
+16.4% vs 2024
-
Total assets
ZAR 9.33 billion
9,325,822 ZAR thousands · p151
+2.5% vs 2024
-
Total equity
ZAR 5.37 billion
5,374,623 ZAR thousands · p151
+13.1% vs 2024
-
Cash from operations
ZAR 1.68 billion
1,677,272 ZAR thousands · p153
+20.3% vs 2024
Large amounts are rounded for reading (ZAR million / billion / trillion); exact figures as printed are under each amount and in the tables. No currency conversion.
Financial statements
Exact figures as printed. Each column comes from one filing; labels are as printed in the newest filing. Amounts in ZAR thousands unless the row says otherwise; brackets are negative.
† from a supplementary filing for the same year · ‡ signed audited statements preferred over a disputed figure · “–” is a printed dash, explained below the table
Column sources
- FY to 30 Sep 2025 — annual report, final status not established; reported for the year · source
- FY to 30 Sep 2024 — annual report, final status not established; comparative in the FY to 30 Sep 2025 filing · source
Income statement
| Line (as printed) | FY to 30 Sep 2025Annual reportreported for the year | FY to 30 Sep 2024Annual reportcomparative in FY to 30 Sep 2025 filing |
|---|---|---|
| Revenue | 22,619,153 | 20,479,785 |
| Cost of sales | (18,654,978) | (16,988,972) |
| Gross profit | 3,964,175 | 3,490,813 |
| Administrative expenses | (1,089,072) | (971,158) |
| Distribution costs | (1,330,672) | (1,326,879) |
| Marketing expenditure1 | (371,689) | (342,692) |
| Other income | 20,701 | 272,016 |
| Other gains2 | 53,926 | 2,809 |
| Profit before interest and tax | 1,247,369 | 1,124,909 |
| Finance income | 18,820 | 39,229 |
| Finance expense | (54,782) | (140,305) |
| Profit before tax | 1,211,407 | 1,023,833 |
| Tax expense | (335,018) | (270,929) |
| Profit for the year | 876,389 | 752,904 |
| Other comprehensive profit for the year, net of tax | 18,620 | (15,065) |
| Items that may subsequently be reclassified to profit and loss3 | 15,864 | (55,912) |
| Currency gain/(loss) on investment loans to foreign subsidiaries4 | 304 | (975) |
| Foreign currency translation loss5 | 15,560 | (54,937) |
| Items that will not be reclassified to profit or loss6 | 2,756 | 40,847 |
| obligations (note 25)7 | 3,231 | (4,073) |
| Deferred tax on re-measurement of post-employment benefit obligations8 | (872) | 1,100 |
| Changes in fair value of equity instruments9 | 397 | 43,820 |
| Total comprehensive income for the year | 895,009 | 737,839 |
| Equity holders of the Company10 | 895,009 | 737,839 |
Notes and alternative reported figures (10)
- “Marketing expenditure” is an issuer-specific line, not mapped to a shared definition: Marketing expenditure.
- “Other gains” is an issuer-specific line, not mapped to a shared definition: Note 5.
- “Items that may subsequently be reclassified to profit and loss” is an issuer-specific line, not mapped to a shared definition: OCI subtotal.
- “Currency gain/(loss) on investment loans to foreign subsidiaries” is an issuer-specific line, not mapped to a shared definition: OCI, reclassifiable.
- “Foreign currency translation loss” is an issuer-specific line, not mapped to a shared definition: OCI, reclassifiable.
- “Items that will not be reclassified to profit or loss” is an issuer-specific line, not mapped to a shared definition: OCI subtotal.
- “obligations (note 25)” is an issuer-specific line, not mapped to a shared definition: OCI, not reclassified.
- “Deferred tax on re-measurement of post-employment benefit obligations” is an issuer-specific line, not mapped to a shared definition: OCI, not reclassified.
- “Changes in fair value of equity instruments” is an issuer-specific line, not mapped to a shared definition: OCI, not reclassified.
- “Equity holders of the Company” is an issuer-specific line, not mapped to a shared definition: Attribution of total comprehensive income.
Balance sheet
| Line (as printed) | FY to 30 Sep 2025Annual reportreported for the year | FY to 30 Sep 2024Annual reportcomparative in FY to 30 Sep 2025 filing |
|---|---|---|
| Property, plant and equipment | 3,235,328 | 3,125,437 |
| Intangible assets | 33,642 | 37,335 |
| Right-of-use assets | 285,922 | 178,114 |
| Goodwill1 | 120,536 | 120,536 |
| Non-current assets (unlabelled total) | 3,675,428 | 3,461,422 |
| Biological assets2 | 1,401,122 | 1,331,399 |
| Inventories | 1,024,934 | 1,553,365 |
| Trade and other receivables | 2,183,808 | 1,987,404 |
| Cash and cash equivalents | 1,040,530 | 739,188 |
| Current assets before assets held for sale (unlabelled)3 | 5,650,394 | 5,611,356 |
| Assets held for sale4 | –5 | 25,008 |
| Current assets (unlabelled total) | 5,650,394 | 5,636,364 |
| Total assets | 9,325,822 | 9,097,786 |
| Ordinary shares | 429 | 429 |
| Share premium | 89,971 | 89,971 |
| Other reserves6 | (73,299) | (87,964) |
| Treasury shares7 | (256,085) | (269,543) |
| Retained earnings | 5,613,607 | 5,019,468 |
| Total equity | 5,374,623 | 4,752,361 |
| Deferred tax liabilities | 900,291 | 708,045 |
| Employee benefit obligations8 | 143,860 | 115,994 |
| Lease obligations | 205,150 | 126,126 |
| Non-current liabilities (unlabelled total) | 1,249,301 | 950,165 |
| Trade and other payables | 2,188,849 | 2,177,932 |
| Employee benefit obligations8 | 341,106 | 375,071 |
| Current tax liabilities | 51,731 | 29,940 |
| Lease obligations | 88,702 | 57,378 |
| Bank overdraft and borrowings9 | 28,024 | 751,589 |
| Shareholders for dividend10 | 3,486 | 3,350 |
| Current liabilities (unlabelled total) | 2,701,898 | 3,395,260 |
| Total liabilities | 3,951,199 | 4,345,425 |
| Total equity and liabilities | 9,325,822 | 9,097,786 |
- Printed “–”, read as nil: subtotal_arithmetic: bs.current_assets.
Notes and alternative reported figures (9)
- “Goodwill” is an issuer-specific line, not mapped to a shared definition: Note 15.
- “Biological assets” is an issuer-specific line, not mapped to a shared definition: Note 17 (current).
- “Current assets before assets held for sale (unlabelled)” is an issuer-specific line, not mapped to a shared definition: Unlabelled subtotal before assets held for sale.
- “Assets held for sale” is an issuer-specific line, not mapped to a shared definition: Note 37.
- “Other reserves” is an issuer-specific line, not mapped to a shared definition: Note 22.
- “Treasury shares” is an issuer-specific line, not mapped to a shared definition: Treasury shares (deducted from equity).
- “Employee benefit obligations” is an issuer-specific line, not mapped to a shared definition: Note 24.
- “Bank overdraft and borrowings”: mapping to a shared definition is uncertain. Bank overdraft and borrowings, one line (note 27).
- “Shareholders for dividend” is an issuer-specific line, not mapped to a shared definition: Unclaimed dividends payable.
Cash flow
| Line (as printed) | FY to 30 Sep 2025Annual reportreported for the year | FY to 30 Sep 2024Annual reportcomparative in FY to 30 Sep 2025 filing |
|---|---|---|
| Cash operating profit/(loss)1 | 1,527,687 | 1,677,604 |
| Changes in working capital2 | 276,297 | (221,475) |
| Cash generated from/(utilised by) operations | 1,803,984 | 1,456,129 |
| Tax paid | (126,712) | (61,580) |
| Cash generated from/(utilised by) operating activities | 1,677,272 | 1,394,549 |
| Cash (outflows)/inflows from investing activities | (239,962) | (77,407) |
| Purchases of property, plant and equipment | (326,333) | (265,560) |
| Costs incurred on intangibles | (1,912) | (2,643) |
| Proceeds on disposal of property, plant and equipment | 69,467 | 9,992 |
| Proceeds from disposal of investments3 | –4 | 141,575 |
| Finance income5 | 18,820 | 39,229 |
| purchase of additional shares6 | (4) | –4 |
| Cash (outflows)/inflows from financing activities | (430,219) | (821,809) |
| Dividends paid to the Company’s shareholders | (284,870) | –7 |
| Lease payments – capital element | (80,103) | (100,607) |
| Finance cost paid on lease contracts | (29,058) | (21,326) |
| Share Plan8 | (12,949) | (28,390) |
| Finance expenses paid | (15,326) | (112,762) |
| Repayment of borrowings | (25,310) | (574,690) |
| Proceeds from the sale of treasury shares9 | 17,397 | 15,966 |
| Net inflow/(outflow) of cash and cash equivalents | 1,007,091 | 495,333 |
| Effects of exchange rate changes | (7,511) | (51,754) |
| Cash and cash equivalents at beginning of year | 12,926 | (430,653) |
| Cash and cash equivalents at end of year | 1,012,506 | 12,926 |
- Printed “–”, read as nil: subtotal_arithmetic: cf.cash_from_investing.
- Printed “–”, read as nil: subtotal_arithmetic: cf.cash_from_financing.
Notes and alternative reported figures (7)
- “Cash operating profit/(loss)” is an issuer-specific line, not mapped to a shared definition: Note A.
- “Changes in working capital” is an issuer-specific line, not mapped to a shared definition: Note B.
- “Proceeds from disposal of investments” is an issuer-specific line, not mapped to a shared definition: Investing.
- “Finance income”: mapping to a shared definition is uncertain. Printed 'Finance income' within investing activities (equal to the finance income in profit or loss).
- “purchase of additional shares” is an issuer-specific line, not mapped to a shared definition: Investing.
- “Share Plan” is an issuer-specific line, not mapped to a shared definition: Financing.
- “Proceeds from the sale of treasury shares” is an issuer-specific line, not mapped to a shared definition: Financing.
Segments
Segment data not yet collected for this company in the pilot.
Dividends
Proposed or recommended, declared and paid are different events and are kept apart. A statement that no dividend was proposed does not mean none was paid.
| Year ended | Event | Wording as printed | Amount | Unit | Source |
|---|---|---|---|---|---|
| 30 Sep 2025 | Dividend declared per share, as printed in a statement | Dividends declared in respect of the current year’s profitsDividends declared in respect of the year's profits, in cents per share (note 10). |
11.00 | ZAR per share | Annual report, p150 |
| 30 Sep 2025 | Dividends paid (cash flow statement) | Dividends paid to the Company’s shareholders |
(284,870) | ZAR thousands | Annual report, p153 |
| 30 Sep 2024 | Dividend declared per share, as printed in a statement | Dividends declared in respect of the current year’s profits (2024)Dividends declared in respect of the year's profits, cents per share, 2024 column. |
5.20 | ZAR per share | Annual report, p150 |
| 30 Sep 2024 | Dividends paid (cash flow statement) | Dividends paid to the Company’s shareholders |
0printed “–”, read as nil | ZAR thousands | Annual report, p153 |
Sources
Each filing used on this page, newest period first. Dates are the document's own; the date we retrieved a file is shown separately and is never a publication date.
-
Astral Integrated Report for the year ended 30 September 2025
Year ended 30 September 2025 · Annual report · final status not established
Audit: Deloitte & Touche (Sebastian Carter, Partner), unmodified opinion
Auditor's sign-off: Deloitte & Touche, per Sebastian Carter, Partner
Final status: The Integrated Report reproduces the independent auditor's report on the consolidated and separate financial statements (Deloitte & Touche, Registered Auditor, per Sebastian Carter, Partner), unqualified, dated 14 November 2025, with the firm and partner names typeset and no signature image (PDF pp147-149, page image). The Board's approval on 12 November 2025 is printed with the typeset names GD Arnold (CEO) and JAI Ferreira (CFO), no signature image (PDF p140). A signed copy would settle the final status.
- Document date
- 14 Nov 2025
- Auditor's report
- 14 Nov 2025
- Board approval
- 12 Nov 2025
- Retrieved by us
- 8 Oct 2026 (not a publication date)
- Used for
- statement columns FY to 30 Sep 2025, FY to 30 Sep 2024
- Basis
- consolidated statements · ZAR thousands (printed “R’000”)
- Cash and cash equivalents in the statement of cash flows (1 012 506; 2024: 12 926) are net of bank overdrafts included in 'Bank overdraft and borrowings'; the balance sheet shows cash of 1 040 530 (2024: 739 188). Investing and financing totals are printed on their heading lines above the items.
- Dividends declared in respect of the year's profits (1 100 cents; 2024: 520 cents) are printed under the statement of comprehensive income with the % change between the years; per-share figures in cents.
Technical details
- File
- 220 pages, with a text layer
- SHA-256
c62a71dd2d764400b2ad56b99e617533737e8f56d0db2572ff22dae5712b5c6f- Entity as printed
- Astral Foods Limited and its subsidiaries
- Issuer copy
- retrieved 2026-10-08T18:52:55Z
Data notes
No figure-level notes beyond those in the tables.
Review status: every figure has been located on its cited source page in an AI-assisted source verification (matched to the document's text) (9 October 2026). Independent review is pending for every figure; automated checks and the AI-assisted verification are not independent review.
Download
Figures shown on this page (CSV) — the same selected figures at their exact printed values, each with its source document, SHA-256, page, selection rule and reading. Independent review of these figures is pending.
South Africa country page · Company methodology and coverage